Skip to main content
Erschienen in: European Radiology 2/2022

26.08.2021 | Nuclear Medicine

Diagnostic and prognostic values of 2-[18F]FDG PET/CT in resectable thymic epithelial tumour

verfasst von: Sangwon Han, Yong-il Kim, Jungsu S. Oh, Seung Yeon Seo, Min-Jae Park, Geun Dong Lee, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Jin-Sook Ryu

Erschienen in: European Radiology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We aimed to evaluate the diagnostic ability for the prediction of histologic grades and prognostic values on recurrence and death of pretreatment 2-[18F]FDG PET/CT in patients with resectable thymic epithelial tumours (TETs).

Methods

One hundred and fourteen patients with TETs who underwent pretreatment 2-[18F]FDG PET/CT between 2012 and 2018 were retrospectively evaluated. TETs were classified into three histologic subtypes: low-risk thymoma (LRT, WHO classification A/AB/B1), high-risk thymoma (HRT, B2/B3), and thymic carcinoma (TC). Area under the receiver operating characteristics curve (AUC) was used to assess the diagnostic performance of PET/CT variables (maximum standardised uptake value [SUVmax], metabolic tumour volume [MTV], total lesion glycolysis [TLG], maximum diameter). Cox proportional hazards models were built using PET/CT and clinical variables.

Results

The tumours included 52 LRT, 33 HRT, and 29 TC. SUVmax showed good diagnostic ability for differentiating HRT/TC from LRT (AUC 0.84, 95% confidence interval [CI] 0.76 − 0.92) and excellent ability for differentiating TC from LRT/HRT (AUC 0.94, 95% CI 0.90 − 0.98), with significantly higher values than MTV, TLG, and maximum diameter. With an optimal cut-off value of 6.4, the sensitivity, specificity, and accuracy for differentiating TC from LRT/HRT were 69%, 96%, and 89%, respectively. In the multivariable Cox proportional hazards analyses for freedom-from-recurrence, SUVmax was an independent prognostic factor (p < 0.001), whereas MTV and TLG were not. SUVmax was a significant predictor for overall survival in conjunction with clinical stage and resection margin.

Conclusion

SUVmax showed excellent diagnostic performance for prediction of TC and significant prognostic value in terms of recurrence and survival.

Key Points

• Maximum standardised uptake value (SUVmax) shows excellent performance in the differentiation of thymic carcinoma from low- and high-risk thymoma.
• SUVmax is an independent prognostic factor for freedom-from-recurrence in the multivariable Cox proportional hazard model and a significant predictor for overall survival.
• 2-[ 18 F]FDG PET/CT can provide a useful diagnostic and prognostic imaging biomarker in conjunction with histologic classification and stage and help choose appropriate management for thymic epithelial tumours.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lee HS, Oh JS, Park YS, Jang SJ, Choi IS, Ryu JS (2016) Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Ann Nucl Med 30:309–319CrossRef Lee HS, Oh JS, Park YS, Jang SJ, Choi IS, Ryu JS (2016) Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Ann Nucl Med 30:309–319CrossRef
2.
Zurück zum Zitat Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart, 3rd edn. IARC Press, Lyon Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart, 3rd edn. IARC Press, Lyon
3.
Zurück zum Zitat Okumura M, Ohta M, Tateyama H et al (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94:624–632CrossRef Okumura M, Ohta M, Tateyama H et al (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94:624–632CrossRef
4.
Zurück zum Zitat Marchevsky AM, Gupta R, McKenna RJ et al (2008) Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 112:2780–2788CrossRef Marchevsky AM, Gupta R, McKenna RJ et al (2008) Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 112:2780–2788CrossRef
5.
Zurück zum Zitat Yun JK, Lee GD, Kim HR et al (2019) A nomogram for predicting recurrence after complete resection for thymic epithelial tumors based on the TNM classification: A multi-institutional retrospective analysis. J Surg Oncol 119:1161–1169CrossRef Yun JK, Lee GD, Kim HR et al (2019) A nomogram for predicting recurrence after complete resection for thymic epithelial tumors based on the TNM classification: A multi-institutional retrospective analysis. J Surg Oncol 119:1161–1169CrossRef
6.
Zurück zum Zitat Falkson CB, Bezjak A, Darling G et al (2009) The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 4:911–919CrossRef Falkson CB, Bezjak A, Darling G et al (2009) The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 4:911–919CrossRef
7.
Zurück zum Zitat Lucchi M, Melfi F, Dini P et al (2006) Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 1:308–313CrossRef Lucchi M, Melfi F, Dini P et al (2006) Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 1:308–313CrossRef
8.
Zurück zum Zitat Detterbeck FC, Moran C, Huang J et al (2011) Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 6:S1730-1738CrossRef Detterbeck FC, Moran C, Huang J et al (2011) Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 6:S1730-1738CrossRef
9.
Zurück zum Zitat Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ (2004) Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 183:283–289CrossRef Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ (2004) Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 183:283–289CrossRef
10.
Zurück zum Zitat Tomiyama N, Johkoh T, Mihara N et al (2002) Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol 179:881–886CrossRef Tomiyama N, Johkoh T, Mihara N et al (2002) Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol 179:881–886CrossRef
11.
Zurück zum Zitat Sadohara J, Fujimoto K, Müller NL et al (2006) Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 60:70–79CrossRef Sadohara J, Fujimoto K, Müller NL et al (2006) Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 60:70–79CrossRef
12.
Zurück zum Zitat Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746–3753CrossRef Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746–3753CrossRef
13.
Zurück zum Zitat Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F (2014) Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Lung Cancer 86:5–13CrossRef Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F (2014) Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Lung Cancer 86:5–13CrossRef
14.
Zurück zum Zitat Nakajo M, Jinguji M, Shinaji T et al (2018) Texture analysis of (18)F-FDG PET/CT for grading thymic epithelial tumours: usefulness of combining SUV and texture parameters. Br J Radiol 91:20170546CrossRef Nakajo M, Jinguji M, Shinaji T et al (2018) Texture analysis of (18)F-FDG PET/CT for grading thymic epithelial tumours: usefulness of combining SUV and texture parameters. Br J Radiol 91:20170546CrossRef
15.
Zurück zum Zitat Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA (2006) 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 47:1628–1634PubMed Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA (2006) 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 47:1628–1634PubMed
16.
Zurück zum Zitat Hamaji M, Koyasu S, Omasa M et al (2021) Are volume-dependent parameters in positron emission tomography predictive of postoperative recurrence after resection in patients with thymic carcinoma? Surg Today 51:322–326CrossRef Hamaji M, Koyasu S, Omasa M et al (2021) Are volume-dependent parameters in positron emission tomography predictive of postoperative recurrence after resection in patients with thymic carcinoma? Surg Today 51:322–326CrossRef
17.
Zurück zum Zitat Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M (2014) 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med 28:257–262CrossRef Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M (2014) 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med 28:257–262CrossRef
18.
Zurück zum Zitat Morgan DJ, Bray KM (1994) Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 26:292–307CrossRef Morgan DJ, Bray KM (1994) Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 26:292–307CrossRef
19.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRef
20.
Zurück zum Zitat Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr (2010) Standard outcome measures for thymic malignancies. J Thorac Oncol 5:2017–2023CrossRef Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr (2010) Standard outcome measures for thymic malignancies. J Thorac Oncol 5:2017–2023CrossRef
21.
Zurück zum Zitat Kang L, Chen W, Petrick NA, Gallas BD (2015) Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med 34:685–703CrossRef Kang L, Chen W, Petrick NA, Gallas BD (2015) Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med 34:685–703CrossRef
22.
Zurück zum Zitat Kaira K, Murakami H, Miura S et al (2011) 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med 25:247–253CrossRef Kaira K, Murakami H, Miura S et al (2011) 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med 25:247–253CrossRef
23.
Zurück zum Zitat Thomas A, Mena E, Kurdziel K et al (2013) 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors. Clin Cancer Res 19:1487–1493CrossRef Thomas A, Mena E, Kurdziel K et al (2013) 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors. Clin Cancer Res 19:1487–1493CrossRef
24.
Zurück zum Zitat Moon SH, Kim HS, Cho YS et al (2016) Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor. Lung Cancer 100:24–29CrossRef Moon SH, Kim HS, Cho YS et al (2016) Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor. Lung Cancer 100:24–29CrossRef
25.
Zurück zum Zitat Han S, Kim H, Kim YJ, Suh CH, Woo S (2018) Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in uterine cervical cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 211:1112–1121CrossRef Han S, Kim H, Kim YJ, Suh CH, Woo S (2018) Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in uterine cervical cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 211:1112–1121CrossRef
26.
Zurück zum Zitat Pak K, Cheon GJ, Nam HY et al (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med 55:884–890CrossRef Pak K, Cheon GJ, Nam HY et al (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med 55:884–890CrossRef
27.
Zurück zum Zitat Im HJ, Pak K, Cheon GJ et al (2015) Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42:241–251CrossRef Im HJ, Pak K, Cheon GJ et al (2015) Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42:241–251CrossRef
28.
Zurück zum Zitat Lee J, Cho YS, Kim J, Shim YM, Lee KH, Choi JY (2021) Prognostic significance of metabolic parameters by (18)F-FDG PET/CT in thymic epithelial tumors. Cancers (Basel) 13:712CrossRef Lee J, Cho YS, Kim J, Shim YM, Lee KH, Choi JY (2021) Prognostic significance of metabolic parameters by (18)F-FDG PET/CT in thymic epithelial tumors. Cancers (Basel) 13:712CrossRef
29.
Zurück zum Zitat Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286CrossRef Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286CrossRef
30.
Zurück zum Zitat In J, Lee DK (2018) Survival analysis: part I - analysis of time-to-event. Korean J Anesthesiol 71:182–191CrossRef In J, Lee DK (2018) Survival analysis: part I - analysis of time-to-event. Korean J Anesthesiol 71:182–191CrossRef
31.
Zurück zum Zitat Abraira V, Muriel A, Emparanza JI et al (2013) Reporting quality of survival analyses in medical journals still needs improvement. A minimal requirements proposal. J Clin Epidemiol 66:1340-1346.e1345CrossRef Abraira V, Muriel A, Emparanza JI et al (2013) Reporting quality of survival analyses in medical journals still needs improvement. A minimal requirements proposal. J Clin Epidemiol 66:1340-1346.e1345CrossRef
32.
Zurück zum Zitat Matsumoto K, Ashizawa K, Tagawa T, Nagayasu T (2007) Chest wall implantation of thymic cancer after computed tomography-guided core needle biopsy. Eur J Cardiothorac Surg 32:171–173CrossRef Matsumoto K, Ashizawa K, Tagawa T, Nagayasu T (2007) Chest wall implantation of thymic cancer after computed tomography-guided core needle biopsy. Eur J Cardiothorac Surg 32:171–173CrossRef
33.
Zurück zum Zitat den Bakker MA, Roden AC, Marx A, Marino M (2014) Histologic classification of thymoma: a practical guide for routine cases. J Thorac Oncol 9:S125-130CrossRef den Bakker MA, Roden AC, Marx A, Marino M (2014) Histologic classification of thymoma: a practical guide for routine cases. J Thorac Oncol 9:S125-130CrossRef
34.
Zurück zum Zitat Verghese ET, den Bakker MA, Campbell A et al (2008) Interobserver variation in the classification of thymic tumours–a multicentre study using the WHO classification system. Histopathology 53:218–223CrossRef Verghese ET, den Bakker MA, Campbell A et al (2008) Interobserver variation in the classification of thymic tumours–a multicentre study using the WHO classification system. Histopathology 53:218–223CrossRef
35.
Zurück zum Zitat Tseng YC, Tseng YH, Kao HL et al (2017) Long term oncological outcome of thymoma and thymic carcinoma - an analysis of 235 cases from a single institution. PLoS One 12:e0179527CrossRef Tseng YC, Tseng YH, Kao HL et al (2017) Long term oncological outcome of thymoma and thymic carcinoma - an analysis of 235 cases from a single institution. PLoS One 12:e0179527CrossRef
36.
Zurück zum Zitat Steyerberg EW, Harrell FE Jr (2016) Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol 69:245–247CrossRef Steyerberg EW, Harrell FE Jr (2016) Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol 69:245–247CrossRef
37.
Zurück zum Zitat Liu H, Gu Z, Qiu B et al (2020) A recurrence predictive model for thymic tumors and its implication for postoperative management: a Chinese Alliance for Research in Thymomas Database Study. J Thorac Oncol 15:448–456CrossRef Liu H, Gu Z, Qiu B et al (2020) A recurrence predictive model for thymic tumors and its implication for postoperative management: a Chinese Alliance for Research in Thymomas Database Study. J Thorac Oncol 15:448–456CrossRef
38.
Zurück zum Zitat Wang Y, Xu L, Du T, Gao Y, Wu Z, Luo D (2018) A nomogram predicting recurrence and guiding adjuvant radiation for thymic carcinoma after resection. Ann Thorac Surg 106:257–263CrossRef Wang Y, Xu L, Du T, Gao Y, Wu Z, Luo D (2018) A nomogram predicting recurrence and guiding adjuvant radiation for thymic carcinoma after resection. Ann Thorac Surg 106:257–263CrossRef
Metadaten
Titel
Diagnostic and prognostic values of 2-[18F]FDG PET/CT in resectable thymic epithelial tumour
verfasst von
Sangwon Han
Yong-il Kim
Jungsu S. Oh
Seung Yeon Seo
Min-Jae Park
Geun Dong Lee
Sehoon Choi
Hyeong Ryul Kim
Yong-Hee Kim
Dong Kwan Kim
Seung-Il Park
Jin-Sook Ryu
Publikationsdatum
26.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-021-08230-z

Weitere Artikel der Ausgabe 2/2022

European Radiology 2/2022 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.